Exploring these hypotheses is crucial for understanding whether similar synergistic effects from the co-inhibition of PGF and VEGFA occur in other types of cancer, beyond bladder cancer, and warrants further investigation. The gene discussed is VEGFA; the disease is urinary bladder carcinoma.